Clinical meaning
Central pontine myelinolysis (CPM), now more broadly termed osmotic demyelination syndrome (ODS), is a devastating neurological condition caused by the non-inflammatory destruction of myelin sheaths in the central pons and, in many cases, extrapontine structures (basal ganglia, thalamus, cerebellum, lateral geniculate body, and cerebral white matter). The condition is most commonly iatrogenic, occurring when chronic hyponatremia (serum sodium less than 130 mEq/L present for more than 48 hours) is corrected too rapidly, though it can also occur in other clinical contexts involving rapid osmolar shifts. Understanding the pathogenesis requires detailed knowledge of brain volume regulation, organic osmolyte physiology, oligodendrocyte biology, and the unique vulnerability of pontine white matter to osmotic stress. Under normal conditions, brain cells maintain osmotic equilibrium with the extracellular fluid (ECF) through regulated transport of electrolytes and organic osmolytes. When hyponatremia develops acutely (over hours), the hypotonic ECF causes water to shift into brain cells by osmosis, producing cerebral edema. However, when hyponatremia is chronic (present for more than 48 hours), the brain activates powerful volume regulatory mechanisms to prevent fatal cerebral edema. Brain cells extrude electrolytes (potassium chloride via KCl cotransporters and potassium channels, and sodium chloride via Na+/K+-ATPase) within hours, followed by the slower efflux of organic osmolytes (also called idiogenic osmoles) including myoinositol, taurine, glycerophosphorylcholine, betaine, glutamine, and glutamate over 24-48 hours. These organic osmolytes are small organic molecules that serve as intracellular solutes without disrupting protein function. By extruding these solutes, brain cells reduce their intracellular osmolality to match the hypotonic ECF, water exits the cells, and brain volume returns to near-normal. This is why patients with chronic hyponatremia may be remarkably asymptomatic despite serum sodium levels of 110-120 mEq/L -- the brain has adapted. The critical problem arises during correction of chronic hyponatremia. When the serum sodium is raised, the ECF becomes relatively hypertonic compared to the osmolyte-depleted brain cells. Water is drawn OUT of brain cells by osmosis, producing cellular dehydration and shrinkage. Under normal circumstances, brain cells can re-accumulate electrolytes relatively quickly (hours), but the re-synthesis and re-uptake of organic osmolytes is SLOW, requiring days to weeks. If the serum sodium is corrected faster than the brain's ability to regenerate organic osmolytes, a prolonged state of cellular dehydration develops, and this osmotic stress is the trigger for demyelination. The exact mechanism by which osmotic stress causes selective demyelination is incompletely understood but involves several pathological processes. Oligodendrocytes, the myelin-producing cells of the central nervous system, are particularly vulnerable to osmotic stress due to their high metabolic demands, high surface-area-to-volume ratio, and dependence on organic osmolytes for volume regulation. Osmotic stress causes oligodendrocyte apoptosis through activation of the mitochondrial apoptotic pathway (cytochrome c release, caspase activation). Additionally, rapid correction of hyponatremia disrupts the blood-brain barrier (BBB): the osmotic gradient between plasma and brain tissue causes endothelial cell shrinkage, opening tight junctions and allowing complement components, cytokines, and other plasma proteins to enter the brain parenchyma. Complement activation in the myelin-rich pons triggers the complement membrane attack complex (MAC, C5b-9), which directly damages myelin sheaths and oligodendrocyte membranes. The pons is particularly vulnerable because of its unique cytoarchitecture: the pontine white matter has a dense admixture of gray and white matter elements with an unusually rich capillary network, creating a large blood-brain barrier surface area for complement and cytokine extravasation. Additionally, the pontine basis has a watershed vascular pattern between perforating branches of the basilar artery, making it susceptible to ischemic injury during periods of osmotic stress. The characteristic histological finding in CPM is symmetric, sharply demarcated areas of myelin destruction in the central basis pontis with preservation of axons and neurons -- this pattern of demyelination without axonal destruction distinguishes ODS from infarction or inflammatory demyelination. Oligodendrocyte death and myelin loss are prominent, while neurons and axons passing through the affected region are initially preserved (though they eventually degenerate without myelin support). Extrapontine myelinolysis (EPM) occurs in approximately 10-50% of CPM cases and affects the basal ganglia (caudate, putamen, globus pallidus), thalamus, lateral geniculate body, cerebellum, and subcortical white matter. EPM may occur with or without pontine involvement and produces different clinical manifestations depending on the affected structures (movement disorders, behavioral changes, cognitive impairment). Risk factors for developing ODS include not only rapid sodium correction but also the severity and chronicity of the hyponatremia (the more depleted the organic osmolytes, the greater the vulnerability), chronic alcoholism (which impairs BBB integrity and depletes organic osmolytes through malnutrition), liver transplantation (cyclosporine neurotoxicity and rapid intraoperative osmolar shifts), malnutrition, hypokalemia (concurrent potassium repletion may inadvertently accelerate sodium correction), and burns.